Indonesia Glucose Monitoring Device Market to be dominated by Wearable Glucose Monitoring Devices through 2028
The increase in the number of diabetic patients is expected to drive the growth of Indonesia glucose monitoring device market in the forecast period, 2024-2028.
According to TechSci Research report, “Indonesia Glucose Monitoring Device Market - By Region, Competition Forecast and Opportunities, 2019-2028”, the market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed due to increasing use of non-invasive glucose monitoring. Non-invasive glucose monitoring is a technology that allows for the measurement of blood glucose levels without the need for a blood sample. This contrasts with traditional glucose monitoring methods, such as fingerstick testing, which require a small sample of blood to be taken for analysis. There are several different non-invasive glucose monitoring technologies currently in development, including optical, thermal, and electromagnetic methods. Optical methods use light to measure glucose levels, while thermal methods measure changes in temperature. Electromagnetic methods use radio waves or magnetic fields to measure glucose levels. One of the main advantages of non-invasive glucose monitoring is that it eliminates the need for painful and inconvenient fingerstick testing. It can also potentially provide more frequent and continuous glucose monitoring, which can help people with diabetes better manage their condition.
Major trend which is there in Indonesia glucose monitoring device market is Integration with other health technologies There is a growing trend toward integrating glucose monitoring devices with other health technologies, such as insulin pumps, continuous glucose monitoring systems, and artificial pancreas systems. This integration can provide patients with a more comprehensive and personalized diabetes management experience. Integration with other healthcare technologies can provide individuals with diabetes with a more holistic and seamless approach to managing their condition. Glucose monitoring devices that integrate with insulin pumps can provide individuals with automated insulin dosing based on their glucose levels, which can help to prevent hypoglycemia and hyperglycemia. Glucose monitoring devices that integrate with EHRs can enable healthcare providers to access real-time glucose data and make more informed treatment decisions. This can help to improve patient outcomes and reduce the risk of diabetes-related complications. Glucose monitoring devices that integrate with mobile apps can provide individuals with diabetes with a more user-friendly and engaging experience.
Tough challenge which is being faced by Indonesia glucose monitoring device market is data privacy and security. Glucose monitoring devices collect and store sensitive personal health information, including glucose levels, insulin dosages, and other health-related data. This information is often transmitted wirelessly, either to a mobile app or to a healthcare provider's electronic health record system, which can create vulnerabilities for data privacy and security. One of the main challenges is ensuring that the data is stored securely and only accessible to authorized individuals. In addition, there is a need to ensure that the data is transmitted securely, to prevent interception and unauthorized access. This requires strong encryption protocols, as well as robust authentication and access control mechanisms. Another challenge is ensuring that the data is used ethically and in compliance with data protection regulations. This requires implementing appropriate data governance policies, procedures, and ensuring that individuals are fully informed about how their data will be used and who will have access to it.
The Indonesia glucose monitoring device market can be segmented by product type, component, application, end user, and region. Based on application, Indonesia glucose monitoring device market can be segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes is a chronic metabolic disorder characterized by high levels of glucose (sugar) in the blood. It occurs when the body does not use insulin properly, a hormone that regulates blood sugar levels, or when the pancreas cannot produce enough insulin to keep up with the demand. Type 2 diabetes is the most common form of diabetes, accounting for about 90-95% of all diabetes cases. Risk factors for type 2 diabetes include obesity, physical inactivity, family history of diabetes, age, and certain ethnicities. Symptoms may include increased thirst, frequent urination, fatigue, blurry vision, slow healing of wounds, and tingling or numbness in the hands and feet. However, some people with type 2 diabetes may not have any symptoms at all. It is important for people with type 2 diabetes to monitor their blood sugar levels regularly and to work closely with their healthcare team to manage their condition and prevent complications.
Based on end user, Indonesia glucose monitoring device market can be segmented into home care settings, hospital, others. Home care settings refer to healthcare services and medical devices that can be provided in a patient's home rather than in a hospital or clinic. Glucose monitoring devices designed for home use are typically compact, portable, and easy to use. They allow people with diabetes to monitor their blood sugar levels more frequently and at times that are convenient for them, without the need to visit a healthcare professional. Home care settings can also include telemedicine and remote patient monitoring technologies, which allow healthcare providers to remotely monitor patients' blood sugar levels and other vital signs and provide guidance and support as needed.
Major companies operating in Indonesia glucose monitoring
device market are:
- PT Glucovation Medtech
- PT Alkes Medika Indonesia
- PT Jakarta Medical System
- PT Arkray
- B Braun Melsungen AG
- PT Medtronic Indonesia
- PT Abbott Indonesia.
In 2021: Medtronic, a global medical technology company, announced a collaboration with Indonesia's state-owned healthcare insurance provider, BPJS Kesehatan, to expand access to diabetes care in the country. The collaboration aimed to improve diabetes care by providing more affordable and accessible diabetes management solutions, including glucose monitoring devices.
In 2020: Indonesia-based healthcare startup Alodokter partnered with Abbott to offer patients access to Abbott's FreeStyle Libre continuous glucose monitoring system through the Alodokter platform. This collaboration aimed to improve access to diabetes management tools for patients in Indonesia.
Customers can also request for 10% free customization on this report.
“Indonesia glucose monitoring device market is expected to dominate the market during the forecast period due to an increase in personalized diabetes management solutions. Patients in Indonesia are increasingly looking for personalized diabetes management solutions that consider their individual needs and preferences. Glucose monitoring devices that offer more advanced data analytics and artificial intelligence capabilities can provide patients with more personalized insights and recommendations for diabetes management, which can improve patient outcomes and drive growth in this segment. Besides, increasing concern about healthy lifestyles and increasing expenditure on health and wellness is further expected to create lucrative opportunities for the market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Indonesia Glucose Monitoring Devices Market, By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices), By Component (Glucometer, Test Strips, Lancets, Insulin Pumps, and Others), By Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), By End User (Home Care Settings, Hospital, and Others), By Region, Competition, Forecast and Opportunities, 2028”, has evaluated the future growth potential of Indonesia glucose monitoring device market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Indonesia glucose monitoring device market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com